FDA Focus On Quicker PMA Reviews Gets Results; Review Quality Studied
This article was originally published in The Gray Sheet
Executive Summary
FDA's device office has shown steady improvement in reducing the time it takes to review all types of device premarket applications, according to a report released Nov. 2 by CDRH's Office of Device Evaluation